ToxoTech AB
559234-1456ActiveDeveloping precision-engineered next-generation botulinum neurotoxin therapeutics for neurological disorders.
Oversikt
- 1
- Ansatte
- 738t SEK
- Omsetning
- 2019
- Grunnlagt
Nøkkelbeslutningstakere
Jonathan Ilicki
Board Member
Geoffrey Masuyer
CEO
Pål Stenmark
Vice-CEO
Ellen Walse
Scientist
+1 flere kontakter i Funnelfeedr
Beskrivelse
ToxoTech is a Stockholm-based biopharmaceutical company founded in 2020 as a spin-out from Stockholm University. The organization specializes in advancing the science behind next-generation botulinum neurotoxin (BoNT) therapeutics. Their core technology focuses on engineering improved toxin-receptor...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Bioteknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE559234145601
Beslutningstakere
5 kontakter i FunnelfeedrJonathan Ilicki
Board Member
Geoffrey Masuyer
CEO
Pål Stenmark
Vice-CEO
Andre kontakter
Ellen Walse
Scientist
Sara Persson Košenina
Principal Scientist
Lignende bedrifter
20 lignende bedrifter i Funnelfeedr
MERZ THERAPEUTICS NORDICS AB
Nordic therapeutics company specializing in neurological movement disorder treatments.
MitoTech AB
0 ansatteDeveloping novel small molecules to restore mitochondrial function in diseases.
AB MAvatar
22 ansatteAI platform transforming biomedical data into personalized medicine insights.
NACAMED AS
Developing silicon nanoparticles for controlled, enhanced drug delivery systems.
Tablestat Technologies Nordic AB
1–4 ansatteAI-powered platform for deal sourcing, buyer mapping, and valuation.
Utforsk mer
Spørsmål om ToxoTech AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo